Abstract Details
|
Gayane R. Melikyan, MD, FAAN
(Hamad Medical Coorporation)
PRESENTER |
Dr. Melikyan has nothing to disclose. |
| Jerzy P. Szaflarski, MD, PhD, FAAN (University of Alabama At Birmingham) | Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea. |
| Naveed Akhtar, MD, FAAN (Hamad Medical Corporation) | Dr. Akhtar has nothing to disclose. |
| Saadat Kamran, MD (Hamad General Hospital) | No disclosure on file |
| Hassan Jassim Al Hail, MD, FAAN (HMC) | Dr. Al Hail has nothing to disclose. |
| Dirk T. Deleu, MD, PhD, FRCP, FAAN (Hamad Medical Corporation/Weill Cornell MC) | Dr. Deleu has nothing to disclose. |